Clinical Trials on Alcohol Drinking in Canada
Total 166 results
-
McGill University Health Centre/Research Institute...Merck Sharp & Dohme LLCCompletedFatty Liver | HIV | Nonalcoholic SteatohepatitisCanada
-
University Health Network, TorontoNovo Nordisk A/SEnrolling by invitationDiabetes Mellitus | NAFLD | NASH - Nonalcoholic Steatohepatitis | Liver Transplant; ComplicationsCanada
-
Johane AllardCanadian Institutes of Health Research (CIHR)Active, not recruitingNon-alcoholic Fatty Liver Disease | Morbid ObesityCanada
-
McGill University Health Centre/Research Institute...CIHR Canadian HIV Trials NetworkCompleted
-
Centre hospitalier de l'Université de Montréal...Canadian Institutes of Health Research (CIHR); McGill University Health Centre... and other collaboratorsRecruitingNonalcoholic Steatohepatitis (NASH) | Nonalcoholic Fatty Liver Disease (NAFLD)Canada
-
John SievenpiperCanadian Institutes of Health Research (CIHR); Canada Research Chairs Endowment... and other collaboratorsUnknownHypertension | Obesity | Cardiovascular Disease | Diabetes | Overweight | Metabolic Syndrome | Dyslipidemia | Kidney Injury | Prediabetes | Gout | Dysglycemia | Kidney Disease | Non-alcoholic Fatty Liver Disease (NAFLD)Canada
-
Novartis PharmaceuticalsCompletedObese Patients With Non-alcoholic Steatohepatitis (NASH)Netherlands, Taiwan, Thailand, United States, Israel, Argentina, Russian Federation, Canada
-
Axcella Health, IncRecruitingNon Alcoholic Steatohepatitis (NASH)United States, Canada, United Kingdom, Australia, France, Poland, Puerto Rico
-
Lawson Health Research InstituteCompletedDiabetes Mellitus | Non-alcoholic Fatty Liver DiseaseCanada
-
LMC Diabetes & Endocrinology Ltd.RecruitingType 2 Diabetes | Nonalcoholic SteatohepatitisCanada
-
Enanta Pharmaceuticals, IncICON Clinical Research; Triangle BiostatisticsCompletedNon-Alcoholic SteatohepatitisUnited States, United Kingdom, New Zealand, Canada, France, Puerto Rico
-
Enanta Pharmaceuticals, IncTerminatedNon-Alcoholic SteatohepatitisUnited States, Canada, Puerto Rico, United Kingdom, Argentina, Germany
-
Bird Rock Bio, Inc.Perspectum; ProSciento, Inc.CompletedNAFLDUnited States, Australia, Canada
-
Novartis PharmaceuticalsTerminatedNon-alcoholic Steatohepatitis (NASH)Belgium, Germany, Taiwan, Austria, United States, Spain, Korea, Republic of, Argentina, Australia, Italy, Japan, Singapore, Netherlands, Slovakia, France, Canada, India
-
Inventiva PharmaCompletedNon-Alcoholic Steatohepatitis (NASH)United States, Spain, United Kingdom, France, Belgium, Austria, Switzerland, Australia, Germany, Slovenia, Bulgaria, Canada, Czechia, Italy, Mauritius, Poland
-
Centre hospitalier de l'Université de Montréal...Radiological Society of North America; Centre de Recherche du Centre Hospitalier... and other collaboratorsCompletedStudy of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes (LIRAINS)Type 2 Diabetes | Nonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisCanada
-
University of ManitobaDSM Nutritional Products, Inc.CompletedNAFLD | TYPE 2 DIABETES | METABOLIC SYNDROMECanada
-
University of TorontoCanadian Diabetes Association; The Physicians' Services Incorporated Foundation and other collaboratorsUnknownHypertension | Cardiovascular Disease | Diabetes | Dyslipidemia | Non-alcoholic Fatty Liver Disease | Prediabetes | Gout | DysglycemiaCanada
-
AstraZenecaActive, not recruitingNon-cirrhotic Non-alcoholic Steatohepatitis With FibrosisUnited States, Austria, Italy, Thailand, Germany, Korea, Republic of, Japan, Malaysia, New Zealand, Spain, Taiwan, Turkey, Australia, Israel, Argentina, Canada, Greece, South Africa, United Kingdom, France
-
Gilead SciencesCompletedNon-Alcoholic Steatohepatitis (NASH)United States, Canada
-
MedImmune LLCCompletedNon-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)United States, Puerto Rico
-
Regeneron PharmaceuticalsRecruitingNon-alcoholic Steatohepatitis (NASH) | Metabolic Dysfunction Associated Steatohepatitis (MASH)United States, Korea, Republic of, Puerto Rico, Japan
-
Boehringer IngelheimCompletedNon-alcoholic Steatohepatitis (NASH)United States, Spain, Korea, Republic of, United Kingdom, Australia, Canada, Singapore, Germany, Italy, Malaysia, China, France, Japan, Taiwan, Netherlands, Austria, Israel, New Zealand, Poland, Hong Kong, Belgium, Czechia, Greece, Hu... and more
-
Mirum Pharmaceuticals, Inc.TerminatedNon-Alcoholic SteatohepatitisUnited States, United Kingdom, Canada, Puerto Rico
-
Intercept PharmaceuticalsTerminatedNon Alcoholic Steatohepatitis (NASH)United States, Finland, France, Spain, United Kingdom, Israel, Austria, Italy, Denmark, Germany, Belgium, Switzerland, Puerto Rico, Poland, Australia, Sweden, Serbia, New Zealand, Canada, Hungary, Portugal
-
Centre hospitalier de l'Université de Montréal...Canadian Institutes of Health Research (CIHR); Centre de Recherche du Centre...CompletedHepatitis B | Hepatitis C | Nonalcoholic Steatohepatitis (NASH) | Nonalcoholic Fatty Liver Disease (NAFLD)Canada
-
Novartis PharmaceuticalsAllerganCompletedNon-alcoholic Steatohepatitis (NASH)United States, Belgium, Spain, Canada, Argentina, Israel, Germany, France, Italy, Turkey, Singapore, Russian Federation, United Kingdom, Czechia, Egypt, India, Latvia
-
Novartis PharmaceuticalsTerminatedNon Alcoholic Steatohepatitis (NASH)United States, South Africa, Spain, Germany, Italy, Taiwan, Canada, Korea, Republic of, Singapore, Bulgaria, Estonia, Mexico, Japan, Denmark, United Kingdom, Colombia, Brazil, Belgium, Russian Federation, Puerto Rico, Chile, Argen... and more
-
John SievenpiperCanadian Institutes of Health Research (CIHR); Canada Research Chairs Endowment... and other collaboratorsUnknownHypertension | Obesity | Cardiovascular Disease | Diabetes | Overweight | Metabolic Syndrome | Dyslipidemia | Non-alcoholic Fatty Liver Disease | Prediabetes | Gout | DysglycemiaCanada
-
Genentech, Inc.CompletedDiabetes Mellitus, Type 2 | Non-Alcoholic Fatty Liver DiseaseUnited States, Canada
-
Novo Nordisk A/SActive, not recruitingNon-alcoholic SteatohepatitisSpain, Denmark, Taiwan, Korea, Republic of, Australia, Canada, India, Singapore, United States, Turkey, Poland, Italy, Belgium, Puerto Rico, United Kingdom, Malaysia, Germany, Portugal, Bulgaria, Czechia, France, Greece, Japan, Russian...
-
Novo Nordisk A/SCompletedNon-alcoholic Steatohepatitis | Hepatobiliary DisordersUnited States, Russian Federation, United Kingdom, Denmark, Sweden, Netherlands, Austria, Belgium, Spain, France, Bulgaria, Canada, Australia, Greece, Japan, Finland, Puerto Rico
-
AlbireoCompleted
-
Ali AminianNot yet recruitingObesity | Liver Fibrosis | Non-Alcoholic Fatty Liver Disease | Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) | Metabolic Dysfunction-Associated Steatohepatitis (MASH)United States, Sweden, Ireland, Finland, United Kingdom, Spain, Switzerland, Brazil, Canada, Italy, Kuwait, India, Mexico
-
Novo Nordisk A/SRecruitingNon-alcoholic SteatohepatitisUnited States, Korea, Republic of, Australia, Taiwan, Italy, Israel, Canada, Netherlands, Czechia, Malaysia, Spain, Denmark, China, United Kingdom, Singapore, Japan, Puerto Rico, Portugal, Switzerland, Ireland, Belgium, Romania, Ger... and more
-
PfizerCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Canada
-
PfizerCompletedNon-alcoholic SteatohepatitisUnited States, Canada
-
Gilead SciencesTerminatedLiver Fibrosis Due to NASHUnited States, Spain, France, Canada, Germany, Italy, Puerto Rico, United Kingdom, Belgium
-
CelgeneTerminatedLiver Cirrhosis | Non-alcoholic Fatty Liver DiseaseUnited States, Spain, Australia, Korea, Republic of, Canada, Germany, France, Japan, United Kingdom, Poland
-
Boehringer IngelheimCompletedNon-alcoholic Fatty Liver DiseaseUnited States, Spain, United Kingdom, Belgium, Canada, Germany, Netherlands, France, Ireland
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH)Canada, United States, Hong Kong, United Kingdom, Switzerland, New Zealand
-
GlaxoSmithKlineRecruitingNonalcoholic Fatty Liver DiseaseUnited States, Australia, Italy, Japan, Spain, Belgium, Argentina, Canada, United Kingdom, Korea, Republic of, France, Greece, India, Mexico, Puerto Rico, Turkey, Panama
-
Merck Sharp & Dohme LLCTerminatedNonalcoholic SteatohepatitisKorea, Republic of, United States, Argentina, Australia, Canada, Chile, China, Colombia, France, Germany, Greece, Hong Kong, Israel, Italy, Japan, Malaysia, Mexico, New Zealand, Puerto Rico, Russian Federation, Spain, Sweden, Taiwan, ...
-
Gilead SciencesCompletedNonalcoholic SteatohepatitisHong Kong, United States, Australia, Puerto Rico, New Zealand, Canada
-
Merck Sharp & Dohme LLCCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Argentina, Australia, Canada, France, Israel, Italy, Korea, Republic of, Mexico, New Zealand, Poland, Russian Federation, Spain, Taiwan, Turkey, Ukraine
-
Sagimet Biosciences Inc.CompletedNonalcoholic Fatty Liver DiseaseUnited States, Canada, Puerto Rico, Poland
-
Gilead SciencesNovo Nordisk A/SActive, not recruitingNonalcoholic SteatohepatitisUnited States, Spain, Australia, France, Japan, Puerto Rico, Canada
-
Boston PharmaceuticalsRecruitingNonalcoholic Steatohepatitis (NASH)United States
-
Gilead SciencesTerminatedNonalcoholic SteatohepatitisHong Kong, United States, Spain, United Kingdom, Australia, Taiwan, Belgium, Canada, India, Japan, Korea, Republic of, Singapore, Puerto Rico, France, Israel, Austria, Germany, Italy, Malaysia, New Zealand, Mexico, Poland, Switzerland, Netherlan... and more
-
Gilead SciencesTerminatedNonalcoholic SteatohepatitisUnited States, Spain, Hong Kong, Canada, Belgium, Australia, Taiwan, India, Japan, Korea, Republic of, Singapore, United Kingdom, Israel, Puerto Rico, France, New Zealand, Germany, Austria, Italy, Mexico, Poland, Switzerland